These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 21717052

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. A new interference in some digoxin assays: anti-murine heterophilic antibodies.
    Liendo C, Ghali JK, Graves SW.
    Clin Pharmacol Ther; 1996 Nov; 60(5):593-8. PubMed ID: 8941034
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Endogenous and exogenous digoxin-like immunoreactive substances: impact on therapeutic drug monitoring of digoxin.
    Dasgupta A.
    Am J Clin Pathol; 2002 Jul; 118(1):132-40. PubMed ID: 12109847
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Estimating concentrations of serum total digoxin and digoxin-like immunoreactive substances in patients of cardiac failure with renal insufficiency].
    Li JH, Wu ZG, Xu JQ, Zhou Y.
    Yao Xue Xue Bao; 1997 Jul; 32(3):174-7. PubMed ID: 11327016
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [The significance of digoxin-like immunoreactive factor (DLIF) for intensive care medicine].
    Simon HB, Behrendt W, Stein T.
    Anasth Intensivther Notfallmed; 1990 Jun; 25(3):235-6. PubMed ID: 2168132
    [Abstract] [Full Text] [Related]

  • 18. Minimizing analytical interferences from digoxin-like immunoreactive substances (DLIS) in cases of digoxin toxicity.
    Seccombe DW, Pudek MR, Humphries KH.
    J Forensic Sci; 1987 May; 32(3):650-7. PubMed ID: 3598515
    [Abstract] [Full Text] [Related]

  • 19. Marked digoxin-like immunoreactive factor interference with an enzyme immunoassay.
    Karboski JA, Godley PJ, Frohna PA, Horton MW, Reitmeyer WJ.
    Drug Intell Clin Pharm; 1988 Sep; 22(9):703-5. PubMed ID: 3063480
    [Abstract] [Full Text] [Related]

  • 20. [Endogenous digoxin-like factor in myocardial infarction].
    Bagrov AI, Kuznetsova EA, Fedorova OV.
    Klin Med (Mosk); 1996 Sep; 74(4):15-7. PubMed ID: 8999142
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.